Protalix BioTherapeutics (PLX) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free PLX Stock Alerts $1.15 -0.03 (-2.54%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineProtalix BioTherapeutics (NYSE:PLX) Trading Up 1.7%americanbankingnews.com - April 24 at 3:00 AMProtalix BioTherapeutics, Inc. (PLX) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 16 at 2:19 PMEarnings call: Protalix BioTherapeutics reports fiscal year 2023 resultsuk.investing.com - March 16 at 2:19 PMProtalix BioTherapeutics (NYSE:PLX) Downgraded to "Hold" at StockNews.commarketbeat.com - March 15 at 11:16 PMProduction cuts, geopolitical tensions drive oil rallyca.finance.yahoo.com - March 15 at 3:47 PMProtalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 15 at 1:25 PMPLX: Elfabrio Geographic Expansionfinance.yahoo.com - March 15 at 10:47 AMProtalix BioTherapeutics, Inc.: Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Resultsfinanznachrichten.de - March 14 at 8:43 AMProtalix BioTherapeutics Inc Reports Revenue Growth and Net Income Gain in FY 2023finance.yahoo.com - March 14 at 8:43 AMProtalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Resultsprnewswire.com - March 14 at 6:50 AMHere's what Wall Street expects from Protalix BioTherapeutics's earnings reportmarkets.businessinsider.com - March 13 at 5:33 PMEarnings Preview: Protalix BioTherapeuticsbenzinga.com - March 13 at 5:33 PMProtalix BioTherapeutics (PLX) Scheduled to Post Quarterly Earnings on Thursdaymarketbeat.com - March 13 at 7:39 AMProtalix Biotherapeutics, Inc.edition.cnn.com - March 9 at 1:28 PMProtalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024finance.yahoo.com - March 7 at 8:30 AMProtalix BioTherapeutics (PLX) Set to Announce Quarterly Earnings on Mondaymarketbeat.com - February 25 at 7:32 AMProtalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conferenceprnewswire.com - February 23 at 6:50 AMPLX Mar 2024 1.500 callca.finance.yahoo.com - February 17 at 1:05 AMAbeona issues update on FDA market application for pz-celmsn.com - February 2 at 7:17 AMWill These 3 Biotech Stocks Make Gains in 2024?entrepreneur.com - January 25 at 7:43 AMProtalix BioTherapeutics Issues 2024 Letter to Stockholdersfinance.yahoo.com - December 26 at 7:21 AMProtalix BioTherapeutics (NYSE:PLX) Upgraded by StockNews.com to Buymarketbeat.com - December 25 at 10:16 PMProtalix BioTherapeutics Stock (AMEX:PLX) Insider Tradesbenzinga.com - December 15 at 11:33 PMProtalix BioTherapeutics (NYSE:PLX) Stock Rating Lowered by StockNews.commarketbeat.com - December 15 at 10:13 PMPLX: More Regulatory Approvalsfinance.yahoo.com - November 7 at 9:39 AMProtalix BioTherapeutics, Inc. (AMEX:PLX) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 7 at 9:39 AMAmerican Well, Protalix BioTherapeutics among healthcare moversmsn.com - November 6 at 10:40 AMProtalix BioTherapeutics GAAP EPS of -$0.04 beats by $0.03, revenue of $10.35M beats by $2.71Mmsn.com - November 6 at 8:24 AMProtalix: Q3 Earnings Snapshotwashingtonpost.com - November 6 at 8:24 AMProtalix BioTherapeutics Inc. Q3 loss drops in line with estimatesmarkets.businessinsider.com - November 6 at 8:24 AMProtalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Resultsfinance.yahoo.com - November 6 at 8:24 AMProtalix BioTherapeutics Inc (PLX) Reports Q3 2023 Financial Resultsfinance.yahoo.com - November 6 at 8:24 AMProtalix BioTherapeutics Q3 Earnings Previewmsn.com - November 3 at 12:16 PMUpcoming Earnings Release Paired With Price Target Raise Sends Stock Soaringtheglobeandmail.com - October 31 at 5:34 PMProtalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023finance.yahoo.com - October 30 at 8:03 AMPalatin Technologies, Protalix BioTherapeutics, Arcutis among healthcare moversmsn.com - October 20 at 1:14 PMProtalix BioTherapeutics Issues Statement Regarding Security Situation in Israelfinance.yahoo.com - October 9 at 7:45 AMProtalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As Chairmanmarkets.businessinsider.com - September 12 at 7:50 AMProtalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directorsfinance.yahoo.com - September 12 at 6:58 AMProtalix BioTherapeutics Stock Is A Hold Pending Successful Commercialization Of Elfabriomsn.com - September 6 at 10:23 AMProtalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 6 at 8:23 AMPLX: Second Quarter Resultsmsn.com - August 8 at 11:29 AMProtalix BioTherapeutics beats Q2 top and bottom line estimatesseekingalpha.com - August 8 at 10:04 AMProtalix BioTherapeutics, Inc. (AMEX:PLX) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 8 at 10:04 AMProtalix BioTherapeutics Reports Second Quarter 2023 Financial and Business Resultsfinance.yahoo.com - August 7 at 8:32 AMHere's what Wall Street expects from Protalix BioTherapeutics's earningsmarkets.businessinsider.com - August 6 at 6:13 PMPreview: Protalix BioTherapeutics's Earningsbenzinga.com - August 4 at 7:08 PMProtalix BioTherapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conferencefinance.yahoo.com - August 1 at 7:25 AMProtalix BioTherapeutics to Announce Second Quarter 2023 Financial and Business Results on August 7, 2023finance.yahoo.com - July 31 at 10:30 AMPLX - Protalix BioTherapeutics, Inc.finance.yahoo.com - July 4 at 10:14 PM Get Protalix BioTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details PLX Media Mentions By Week PLX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PLX News Sentiment▼0.000.32▲Average Medical News Sentiment PLX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PLX Articles This Week▼11▲PLX Articles Average Week Get Protalix BioTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AlloVir News Curis News Atara Biotherapeutics News Gritstone bio News CEL-SCI News Cognition Therapeutics News Athira Pharma News Passage Bio News bluebird bio News Vigil Neuroscience News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:PLX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protalix BioTherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
